Abstract:A new technology to the pharmaceutical field is presented: surface decontamination by plasmas The technology is comparable to established barrier systems like e-beam, volatile hydrogen peroxide, or radiation inactivation of microbiological contaminations. This plasma technology is part of a fully automated and validated syringe filling line at a major pharmaceutical company and is in production operation. Incoming pre-sterilized syringe containers ("tubs") are processed by plasma, solely on the outside, and passed into the aseptic filling isolator upon successful decontamination. The objective of this article is to present the operating principles and develop and establish a validation routine on the basis of standard commercial biological indicators. Their decontamination efficacies are determined and correlated to the actual inactivation efficacy on the pharmaceutical packaging material.The reference setup is explained in detail and a short presentation of the cycle development and the relevant plasma control parameters is given, with a special focus on the in-process monitor determining the cycle validity. Different microbial inactivation mechanisms are also discussed and evaluated for their contribution and interaction to enhance plasma decontamination. A material-dependent inactivation behavior was observed. In order to be able to correlate the tub surface inactivation of Geobacillus stearothermophilus endospores to metallic biological indicators, a comparative study was performed. Through consistently demonstrating the linear inactivation behavior between the different materials, it becomes possible to develop an effective and time-saving validation scheme. Lay abstract: The challenge in new decontamination systems lies in a thorough validation of the inactivation efficacy under different operating regimes. With plasma, as an ionized gas, a new barrier concept is introduced into pharmaceutical aseptic processing of syringes. The presented system operates in vacuum and only decontaminates the outer surface of pre-sterilized syringe containers ("tubs"), before they are transferred into the aseptic area. The plasma does not penetrate into the tub. This article discusses the phase from development and test germ selection, across the identified sporicidal mechanisms, to a proposal for a validation scheme on the basis of commercially available biological indicators. A special focus is placed on an extensive investigation to establish a link between the tub surface microbial kill (polystyrene and Tyvek(and (2)) ) and biological indicator inactivation (stainless steel). Additionally, a rationale is developed on how an optical in-process monitor can be applied to establish a validatable limit on the base of the predetermined inactivation data of Geobacillus stearothermophilus endospores.

Design and Development of a Novel Tesla Coil-Based Cold Plasma Device for Plasma Medicine: Decoupling the Effect of Plasma-Generated Species

Bactericidal Effect of Various Non-Thermal Plasma Agents and the Influence of Experimental Conditions in Microbial Inactivation: A Review

State-of-the-art non-thermal plasma disinfection and medicine

A Microsecond-Pulsed Cold Plasma Jet for Medical Application

Rapid Disinfection Performance of a Touchable Pulsed SDBD Nonthermal Plasma

Portable and affordable cold air plasma source with optimized bactericidal effect

A Novel Approach on Dielectric Barrier Discharge Using Printed Circuit Boards

Characterization of an atmospheric pressure plasma jet and its applications for disinfection and cancer treatment

Bacterial Decontamination of Water-Containing Objects Using Piezoelectric Direct Discharge Plasma and Plasma Jet

Preliminary Exploration of Low Frequency Low-Pressure Capacitively Coupled Ar-O2 Plasma

A novel approach to the pacemaker infection with non-thermal atmospheric pressure plasma

Plasma Decontamination: A Case Study on Kill Efficacy of Geobacillus stearothermophilus Spores on Different Carrier Materials

The further development of cold plasma technology: The effectiveness of a contactless, indirect atmospheric cold plasma method for germ reduction on surfaces in vitro and in vivo

Distributed compact plasma reactor decontamination for planetary protection in space missions

Theoretical-Computational Study of Atmospheric DBD Plasma and Its Utility for Nanoscale Biocompatible Plasmonic Coating

A low cost, flexible atmospheric pressure plasma jet device with good antimicrobial efficiency

Cold plasma technology: advanced and sustainable approach for wastewater treatment

The Interaction of a Direct-Current Cold Atmospheric-Pressure Air Plasma with Bacteria

Redox Reactions of Biologically Active Molecules upon Cold Atmospheric Pressure Plasma Treatment of Aqueous Solutions

Antibacterial effects of low-temperature plasma generated by atmospheric-pressure plasma jet are mediated by reactive oxygen species

A rapid prototyped atmospheric non-thermal plasma-activated aerosol device and anti-bacterial characterisation